Travere Therapeutics (NASDAQ:TVTX) is in focus after a fresh update tied to rare disease therapies, with market attention on ...
The Second Circuit closed the books on a novel issue that arose after Evan Greebel was convicted of securities fraud—whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results